These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2446520)

  • 1. Fenoterol, a selective beta 2-adrenergic agonist, and inhibition of IgE-mediated basophil histamine release.
    Morita Y; Miyamoto T
    Allergy; 1987 Oct; 42(7):524-8. PubMed ID: 2446520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of IgE-mediated histamine release from human basophils and mast cells by fenoterol.
    Marone G; Ambrosio G; Bonaduce D; Genovese A; Triggiani M; Condorelli M
    Int Arch Allergy Appl Immunol; 1984; 74(4):356-61. PubMed ID: 6203844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of histamine release from human basophils in vitro by physiological concentrations of zinc.
    Marone G; Findlay SR; Lichtenstein LM
    J Pharmacol Exp Ther; 1981 May; 217(2):292-8. PubMed ID: 6164779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of IgE- and non-IgE-mediated histamine release from human basophil leukocytes in vitro by a histamine H1-antagonist, desethoxycarbonyl-loratadine.
    Kleine-Tebbe J; Josties C; Frank G; Stalleicken D; Buschauer A; Schunack W; Kunkel G; Czarnetzki B
    J Allergy Clin Immunol; 1994 Feb; 93(2):494-500. PubMed ID: 7509820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability.
    Shim JY; Kim BS; Cho SH; Min KU; Hong SJ
    Clin Exp Allergy; 2003 Jan; 33(1):52-7. PubMed ID: 12534549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of interleukin 2 on basophil histamine release.
    Morita Y; Goto M; Miyamoto T
    Allergy; 1987 Feb; 42(2):104-8. PubMed ID: 2438959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of hypertonicity on FMLP-, anti-IgE- and Ca2+ ionophore A23187-induced histamine release from human basophil leukocytes.
    Tedeschi A; Arquati M; Lorini M; Miadonna A
    Int Arch Allergy Appl Immunol; 1990; 93(4):359-64. PubMed ID: 1713571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective inhibition of sodium on basophil histamine release in patients with allergic rhinitis and bronchial asthma.
    Tedeschi A; Cottini M; Salmaso C; Milazzo N; Miadonna A
    Eur Respir J; 1996 Oct; 9(10):2070-6. PubMed ID: 8902469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antibiotics on immediate hypersensitivity reactions in vitro: suppression of IgE-mediated histamine release from peripheral blood basophils by fosfomycin.
    Ida S; Shindoh Y; Takishima T
    Microbiol Immunol; 1987; 31(10):975-84. PubMed ID: 2448594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ionic regulation of human basophil releasability. III. Effects of Na+ and Ca2+ on histamine release induced by different stimuli.
    Tedeschi A; Palella M; Arquati M; Milazzo N; Miadonna A
    Pharmacol Res; 1994; 30(3):229-41. PubMed ID: 7532302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of immunological and non-immunological histamine release from human basophils and lung mast cells by formoterol.
    Subramanian N
    Arzneimittelforschung; 1986 Mar; 36(3):502-5. PubMed ID: 2423094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by galanin and by high K+ of human basophil histamine release triggered by calcium ionophores but not responses induced by anti-IgE, chemotactic peptide or phorbol ester.
    Bergstrand H; Lundquist B; Ahrén B
    Br J Pharmacol; 1991 Jun; 103(2):1381-4. PubMed ID: 1715794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of immunological and nonimmunological histamine release from human basophils by adenosine analogues that act at P-sites.
    Hughes PJ; Church MK
    Biochem Pharmacol; 1986 Jun; 35(11):1809-16. PubMed ID: 2424453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human basophil releasability. III. Genetic control of human basophil releasability.
    Marone G; Poto S; Celestino D; Bonini S
    J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of 5-lipoxygenase pathway activation in basophil histamine release.
    Morita Y; Suzuki S; Miyamoto T
    Int Arch Allergy Appl Immunol; 1985; 78(1):77-80. PubMed ID: 2411671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auranofin, an oral chrysotherapeutic agent, inhibits histamine release from human basophils.
    Takaishi T; Morita Y; Kudo K; Miyamoto T
    J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 1):296-301. PubMed ID: 6206106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human IL-1 alpha and -1 beta potentiate IgE-mediated histamine release from human basophils.
    Massey WA; Randall TC; Kagey-Sobotka A; Warner JA; MacDonald SM; Gillis S; Allison AC; Lichtenstein LM
    J Immunol; 1989 Sep; 143(6):1875-80. PubMed ID: 2476485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonidine inhibits IgE-mediated and IgE-independent in vitro histamine release from human basophil leukocytes.
    Miadonna A; Tedeschi A; Leggieri E; Parravicini P; Lorini M; Zanussi C
    Int J Immunopharmacol; 1989; 11(5):473-7. PubMed ID: 2478489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG- and IgE-mediated histamine release from superfused guinea-pig airway tissues.
    Van Amsterdam RG; Santing RE; De Boer J; Brouwer F; Zaagsma J
    J Pharm Pharmacol; 1991 Oct; 43(10):694-8. PubMed ID: 1719184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basophil releasability in the newborn: factors limiting immunoglobulin E-mediated histamine release.
    Mendoza GR; Minagawa K; Orner FB; Stiehm ER
    Pediatrics; 1982 Feb; 69(2):188-92. PubMed ID: 6173838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.